1. Home
  2. VRAX vs BHAT Comparison

VRAX vs BHAT Comparison

Compare VRAX & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • BHAT
  • Stock Information
  • Founded
  • VRAX 2013
  • BHAT 2010
  • Country
  • VRAX United Kingdom
  • BHAT China
  • Employees
  • VRAX N/A
  • BHAT N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BHAT Recreational Games/Products/Toys
  • Sector
  • VRAX Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • VRAX 7.3M
  • BHAT 8.6M
  • IPO Year
  • VRAX 2022
  • BHAT 2019
  • Fundamental
  • Price
  • VRAX $1.87
  • BHAT $0.05
  • Analyst Decision
  • VRAX
  • BHAT
  • Analyst Count
  • VRAX 0
  • BHAT 0
  • Target Price
  • VRAX N/A
  • BHAT N/A
  • AVG Volume (30 Days)
  • VRAX 304.3K
  • BHAT 195.9M
  • Earning Date
  • VRAX 02-05-2025
  • BHAT 12-23-2024
  • Dividend Yield
  • VRAX N/A
  • BHAT N/A
  • EPS Growth
  • VRAX N/A
  • BHAT N/A
  • EPS
  • VRAX N/A
  • BHAT N/A
  • Revenue
  • VRAX $84,872.00
  • BHAT $40,461,026.00
  • Revenue This Year
  • VRAX $5,169.18
  • BHAT N/A
  • Revenue Next Year
  • VRAX $66.97
  • BHAT N/A
  • P/E Ratio
  • VRAX N/A
  • BHAT N/A
  • Revenue Growth
  • VRAX 7.03
  • BHAT N/A
  • 52 Week Low
  • VRAX $0.60
  • BHAT $0.04
  • 52 Week High
  • VRAX $9.00
  • BHAT $1.45
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 48.66
  • BHAT 43.54
  • Support Level
  • VRAX $1.65
  • BHAT $0.05
  • Resistance Level
  • VRAX $2.10
  • BHAT $0.09
  • Average True Range (ATR)
  • VRAX 0.22
  • BHAT 0.02
  • MACD
  • VRAX 0.01
  • BHAT 0.00
  • Stochastic Oscillator
  • VRAX 42.47
  • BHAT 17.12

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.

Share on Social Networks: